GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Future Medicine Co Ltd (XKRX:341170) » Definitions » EPS (Diluted)

Future Medicine Co (XKRX:341170) EPS (Diluted) : ₩-379.00 (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Future Medicine Co EPS (Diluted)?

Future Medicine Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was ₩-379.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-379.00.

Future Medicine Co's EPS (Basic) for the six months ended in Dec. 2024 was ₩-379.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-379.00.

Future Medicine Co's EPS without NRI for the six months ended in Dec. 2024 was ₩-379.41. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-379.41.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Future Medicine Co EPS (Diluted) Historical Data

The historical data trend for Future Medicine Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Future Medicine Co EPS (Diluted) Chart

Future Medicine Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,622.00 -1,722.00 -785.00 -612.00 -379.00

Future Medicine Co Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,622.00 -1,722.00 -785.00 -612.00 -379.00

Competitive Comparison of Future Medicine Co's EPS (Diluted)

For the Biotechnology subindustry, Future Medicine Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Future Medicine Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Future Medicine Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Future Medicine Co's PE Ratio falls into.


;
;

Future Medicine Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Future Medicine Co's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3993.854-0)/10.538
=-379.00

Future Medicine Co's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3993.854-0)/10.538
=-379.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-379.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Future Medicine Co  (XKRX:341170) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Future Medicine Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Future Medicine Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Future Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
54 changup-ro, 616, 2 Techno Valley Enterprise Growth Center, Gyeonggi-do, Siheung-dong, LH Pangyo-je, Seongnam-si, KOR, 13449
Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.

Future Medicine Co Headlines

No Headlines